(0)

Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Sheraton Boston Hotel

Aug 14, 2017 8:00 AM - Aug 15, 2017 3:30 PM

39 Dalton Street, , Boston, MA 02119 , USA

New Drug Product Development and Life Cycle Management

Back to Agenda

Module 2: Candidate Identification/Preclinical Testing

Session Chair(s)

Courtland R. LaVallee, MBA

Courtland R. LaVallee, MBA

Executive Director, Project Management

Dynavax Technologies, United States

  • Discovery
  • Drug Substance Scale up for Toxicology Testing
  • Simple Formulation for Phase 1 Clinical Work
  • Single Dose/MD Toxicity in Animals up to 14 or 30 Days
  • Development of Biomarkers for Phase 1
  • Summary

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.